Eccentric Overload Muscle Damage is Attenuated by a Novel Angiotensin- (1-7) Treatment

International Journal of Sports Medicine

Volumn 39, Issue 10, 2018, Pages 743-748

  Becker, Lenice Kappes ^a   Totou, Nádia ^b   Moura, Samara ^b   Kangussu, Lucas ^a   Millán, Ruben Dario Sinisterra ^a   Campagnole Santos, Maria Jose ^a   Coelho, Daniel ^b   Motta Santos, Daisy ^a   Santos, Robson Augusto Souza ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

angiotensin (1 7); muscular damage; physical performance

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ANGIOTENSIN I; ANGIOTENSIN I (1-7); BIOLOGICAL MARKER; CREATINE KINASE; CYTOKINE; EXCIPIENT; MESSENGER RNA; PEPTIDE FRAGMENT;

ADULT; BLOOD; CONTROLLED STUDY; DIETARY SUPPLEMENT; DOUBLE BLIND PROCEDURE; EXERCISE; EXERCISE TEST; FEMALE; HUMAN; INJURIES; MALE; METABOLISM; MONONUCLEAR CELL; MUSCLE STRENGTH; MYALGIA; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE; YOUNG ADULT;

2-HYDROXYPROPYL-BETA-CYCLODEXTRIN; ADULT; ANGIOTENSIN I; BIOMARKERS; CREATINE KINASE; CYTOKINES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; EXCIPIENTS; EXERCISE; EXERCISE TEST; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MUSCLE STRENGTH; MUSCLE, SKELETAL; MYALGIA; PEPTIDE FRAGMENTS; RNA, MESSENGER; YOUNG ADULT;

EID: 85049064375     PISSN: 01724622     EISSN: 14393964     Source Type: Journal    
DOI: 10.1055/a-0633-8892     Document Type: Article

References (33)

1. Acuna M. J. Pessina P. Olguin H. Cabrera D. Vio C. P. Bader M. Munoz-Canoves P. Santos R. A. Cabello-Verrugio C. Brandan E. Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-beta signalling. Hum Mol Genet: 2014; 23 1237 1249
2. Baird M. F. Graham S. M. Baker J. S. Bickerstaff G. F. Creatine-kinase- and exercise-related muscle damage implications for muscle performance and recovery. J Nutr Metab: 2012; 2012 960363
3. Baldwin Lanier A. Use of nonsteroidal anti-inflammatory drugs following exercise-induced muscle injury. Sports Med: 2003; 33 177 185
4. Cabello-Verrugio C. Morales M. G. Rivera J. C. Cabrera D. Simon F. Renin-Angiotensin system: An old player with novel functions in skeletal muscle. Med Res Rev: 2015; 35 437 463
5. Cheung K. Hume P. Maxwell L. Delayed onset muscle soreness: Treatment strategies and performance factors. Sports Med: 2003; 33 145 164
6. Cisternas F. Morales M. G. Meneses C. Simon F. Brandan E. Abrigo J. Vazquez Y. Cabello-Verrugio C. Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism. Clin Sci (Lond): 2015; 128 307 319
7. Clarkson P. M. Nosaka K. Braun B. Muscle function after exercise-induced muscle damage and rapid adaptation. Med Sci Sports Exerc: 1992; 24 512 520
8. Costa A. C. Becker L. K. Moraes E. R. Romero T. R. Guzzo L. Santos R. A. Duarte I. D. Angiotensin-(1-7) induces peripheral antinociception through mas receptor activation in an opioid-independent pathway. Pharmacology: 2012; 89 137 144
9. Forte B. L. Slosky L. M. Zhang H. Arnold M. R. Staatz W. D. Hay M. Largent-Milnes T. M. Vanderah T. W. Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain. Pain: 2016; 157 2709 2721
10. Fraga-Silva R. A. Costa-Fraga F. P. De Sousa F. B. Alenina N. Bader M. Sinisterra R. D. Santos R. A. An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect. Clinics (Sao Paulo): 2011; 66 837 841
11. Fraga-Silva R. A. Costa-Fraga F. P. Savergnini S. Q. De Sousa F. B. Montecucco F. da Silva D. Sinisterra R. D. Mach F. Stergiopulos N. da Silva R. F. Santos R. A. An oral formulation of Angiotensin-(1-7) reverses corpus cavernosum damages induced by hypercholesterolemia. J Sex Med: 2013; 10 2430 2442
12. Hamada K. Vannier E. Sacheck J. M. Witsell A. L. Roubenoff R. Senescence of human skeletal muscle impairs the local inflammatory cytokine response to acute eccentric exercise. FASEB J: 2005; 19 264 266
13. Harriss D. J. Macsween A. Atkinson G. Standards for ethics in sport and exercise science research: 2018 update. Int J Sports Med: 2017; 38 1126 1131
14. Lombardi G. Ziemann E. Banfi G. Whole-body cryotherapy in athletes: From therapy to stimulation. An updated review of the literature. Front Physiol: 2017; 8 258
15. Lula I. Denadai A. L. Resende J. M. de Sousa F. B. de Lima G. F. Pilo-Veloso D. Heine T. Duarte H. A. Santos R. A. Sinisterra R. D. Study of angiotensin-(1-7) vasoactive peptide and its beta-cyclodextrin inclusion complexes: Complete sequence-specific NMR assignments and structural studies. Peptides: 2007; 28 2199 2210
16. MacIntyre D. L. Reid W. D. McKenzie D. C. Delayed muscle soreness. The inflammatory response to muscle injury and its clinical implications. Sports Med: 1995; 20 24 40
17. Marques F. D. Ferreira A. J. Sinisterra R. D. Jacoby B. A. Sousa F. B. Caliari M. V. Silva G. A. Melo M. B. Nadu A. P. Souza L. E. Irigoyen M. C. Almeida A. P. Santos R. A. An oral formulation of angiotensin-(1-7) produces cardioprotective effects in infarcted and isoproterenol-treated rats. Hypertension: 2011; 57 477 483
18. Marques F. D. Melo M. B. Souza L. E. Irigoyen M. C. Sinisterra R. D. de Sousa F. B. Savergnini S. Q. Braga V. B. Ferreira A. J. Santos R. A. Beneficial effects of long-term administration of an oral formulation of Angiotensin-(1-7) in infarcted rats. Int J Hypertens: 2012; 2012 795452
19. McCollum L. T. Gallagher P. E. Ann Tallant E. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1. Am J Physiol Heart Circ Physiol: 2012; 302 H801 H810
20. Motta-Santos D. Dos Santos R. A. Oliveira M. Qadri F. Poglitsch M. Mosienko V. Kappes Becker L. Campagnole-Santos M. J. Penninger J. M. Alenina N. Bader M. Effects of ACE2 deficiency on physical performance and physiological adaptations of cardiac and skeletal muscle to exercise. Hypertens Res: 2016; 39 506 512
21. Oliveira Andrade J. M. Paraiso A. F. Garcia Z. M. Ferreira A. V. Sinisterra R. D. Sousa F. B. Guimaraes A. L. de Paula A. M. Campagnole-Santos M. J. dos Santos R. A. Santos S. H. Cross talk between angiotensin-(1-7)/Mas axis and sirtuins in adipose tissue and metabolism of high-fat feed mice. Peptides: 2014; 55 158 165
22. Pachauri P. Garabadu D. Goyal A. Upadhyay P. K. Angiotensin (1-7) facilitates cardioprotection of ischemic preconditioning on ischemia-reperfusion-challenged rat heart. Mol Cell Biochem: 2017; 430 99 113
23. Paschalis V. Koutedakis Y. Jamurtas A. Z. Mougios V. Baltzopoulos V. Equal volumes of high and low intensity of eccentric exercise in relation to muscle damage and performance. J Strength Cond Res: 2005; 19 184 188
24. Proença J. K. Estudo clínico (FASE1) da farmacocinética e tolerabilidade de uma nova formulação oral do peptídeo angiotensina-(1-7) incluído em HP-beta-ciclodextrina em voluntários saudáveis. Universidade Federal de Minas Gerais: 2016
25. Puthucheary Z. Skipworth J. R. Rawal J. Loosemore M. Van Someren K. Montgomery H. E. The ACE gene and human performance: 12 years on. Sports Med: 2011; 41 433 448
26. Romain C. Freitas T. T. Martinez-Noguera F. J. Laurent C. Gaillet S. Chung L. H. Alcaraz P. E. Cases J. Supplementation with a polyphenol-rich extract, TensLess((R)), attenuates delayed onset muscle soreness and improves muscle recovery from damages after eccentric exercise. Phytother Res: 2017; 31 1739 1746
27. Saka T. Akova B. Yazici Z. Sekir U. Gür H. Ozarda Y. Difference in the magnitude of muscle damage between elbow flexors and knee extensors eccentric exercises. J Sports Sci Med: 2009; 8 107 115
28. Santos RA S. Sampaio W. O. Alzamora A. C. Motta-Santos D. Alenina N. Bader M. Campagnole-Santos M. J. The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7). Physiol Rev: 2018; 98 505 553
29. Sayers S. P. Clarkson P. M. Short-term immobilization after eccentric exercise. Part II: Creatine kinase and myoglobin. Med Sci Sports Exerc: 2003; 35 762 768
30. Silva J. R. Rumpf M. C. Hertzog M. Castagna C. Farooq A. Girard O. Hader K. Acute and residual soccer match-related fatigue: A systematic review and meta-analysis. Sports Med: 2018; 48 539 583
31. Townsend J. R. Fragala M. S. Jajtner A. R. Gonzalez A. M. Wells A. J. Mangine G. T. Robinson E. Ht. McCormack W. P. Beyer K. S. Pruna G. J. Boone C. H. Scanlon T. M. Bohner J. D. Stout J. R. Hoffman J. R. beta-Hydroxy-beta-methylbutyrate (HMB)-free acid attenuates circulating TNF-alpha and TNFR1 expression postresistance exercise. J Appl Physiol (1985): 2013; 115 1173 1182
32. Warren G. L. Lowe D. A. Armstrong R. B. Measurement tools used in the study of eccentric contraction-induced injury. Sports Med: 1999; 27 43 59
33. Zainuddin Z. Newton M. Sacco P. Nosaka K. Effects of massage on delayed-onset muscle soreness, swelling, and recovery of muscle function. J Athl Train: 2005; 40 174 180